Ramsay Health Care, Australia’s second-largest private hospital group, has hired investment bank Goldman Sachs to explore options for its underperforming European division, Ramsay Santé. This move hints at a potential sale.
Global private equity firm KKR has provided a financing solution to Family Doctor, an Australian GP clinic network, to support its growth and acquisitions. As HBI understands, Dr. Aziz will retain 100% ownership and KKR’s Asia Pacific Credit strategy intends to start with an initial A$170 million facility.
On March 5th 2025 the European Health Data Space (EHDS) Regulation was published in the Official Journal of the European Union. The European Commission describes the EHDS as "a game changer for healthcare in Europe" that aims to transform how health data is accessed, used, and shared across the EU.
A veterinary services business is fast becoming a ‘must have’ for every private equity healthcare portfolio. And with that in mind, HBI spoke with Daniel Einhorn, founder and former CEO of French veterinary services provider Sevetys, to better understand why they are such a compelling addition.
A new GP contract will “fix the front door” of the NHS and bring back the family doctor, the government has announced. The new deal agreed with the British Medical Association (BMA) will free up doctors from box-ticking targets to concentrate on patients and take first steps to end the “8am scramble” for appointments.
Burjeel Holdings, a major private hospital and primary healthcare provider in MENA, has secured AED 225 million ($61.27 million) in new Operations and Management (O&M) contracts, expanding its presence in the UAE’s healthcare sector.
The share price of listed pan-European French elderly care group Clariane shot up 33% last week, after the release of 2024 results showing a return to profitability.
Spain-based pan-European REIT Healthcare Activos has presented a “strategic roadmap” for expanding Europe’s elderly care capacity to MEPs at the European Parliament, given that the continent’s 80+ population will roughly double by 2050.
Fresenius, Germany’s largest for-profit hospital group, has just released its 2024 annual results, and CEO Michael Sen’s “Future Fresenius” strategy is in full swing.
The company beat market expectations for FY24 earnings, with strong performance from its hospital drug unit, Kabi. The unit saw a 21% jump in EBIT year-on-year, hitting €340 million, driven by solid revenue growth and better productivity.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.